Ajay Tuli, MD
Interventional Cardiology · Tucson, AZNPI 1093793267
Payments from drug & device makers
Across 958 payments — averaging $736.05 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Eli Lilly$423K
- Novartis$200K
- Amgen$69K
- Abiomed$2K
- Biotronik Inc.$2K
- Abbott$1K
- plus $8K from 28 others
Across 1 payment — averaging $46,230 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Eli Lilly$46K
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Eli Lilly | 4 | $423,478 |
| Novartis | 194 | $199,789 |
| Amgen | 46 | $69,449 |
| Abiomed | 86 | $1,983 |
| Biotronik Inc. | 6 | $1,518 |
| Abbott | 191 | $1,340 |
| Canon Medical Systems USA, Inc. | 3 | $1,085 |
| Pfizer | 76 | $927 |
| Johnson & Johnson | 135 | $860 |
| Actelion Pharmaceuticals US, Inc. | 56 | $686 |
| E.r. Squibb & Sons, L.L.C. | 36 | $496 |
| Merck | 21 | $405 |
| Boston Scientific | 12 | $325 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 20 | $312 |
| Cvrx, Inc. | 9 | $303 |
| Edwards Lifesciences | 4 | $282 |
| ZOLL Respicardia, Inc. | 1 | $239 |
| Medtronic(2 entities) | 4 | $210 |
| Philips North America LLC | 4 | $199 |
| Bayer | 4 | $174 |
| Kowa Pharmaceuticals America, Inc. | 2 | $154 |
| AstraZeneca | 9 | $150 |
| Impulse Dynamics (USA) Inc. | 2 | $134 |
| Inspire Medical Systems, Inc. | 1 | $117 |
| Astellas Pharma US Inc | 7 | $93 |
| Boehringer Ingelheim | 5 | $92 |
| Amarin Pharma, Inc. | 5 | $84 |
| Esperion Therapeutics, Inc. | 5 | $79 |
| Sanofi-aventis U.S. LLC | 4 | $53 |
| Novo Nordisk | 2 | $44 |
| Bridgebio Pharma, Inc. | 1 | $21 |
| Cordis US CORP. | 1 | $21 |
| Alnylam Pharmaceuticals Inc. | 1 | $17 |
| Kiniksa Pharmaceuticals, Ltd. | 1 | $17 |
How this compares
$705,136 in reported general payments places this provider in the 95th percentile of 223 interventional cardiology providers in Arizona.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other interventional cardiology in Tucson
- Thomas WaggonerTucson$4.1M
- Kapildeo LotunTucson$488K
- Neil GheewalaTucson$319K
- Ryan TsudaTucson$245K
- Michel CorbanTucson$106K
- Dexter de LeonTucson$90K
- William ThomasTucson$71K
- Brenda PeartTucson$66K
- Ranjith ShettyTucson$50K
- Santiago RamirezTucson$45K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.